Thank you for being part of the GRADUATE 1 or GRADUATE 2 studies. We would like to hear from you about your experience. Your feedback could help other people with Alzheimer’s disease.
Dr David Watson, a specialist in Alzheimer’s disease on the GRADUATE study team, explains how you can help.
You were either a study participant or a study partner in one of the GRADUATE studies. Your responses could help other people with early Alzheimer’s disease and their caregivers in the future.
Information about this interview is provided on this website to help you decide whether participation is right for you. It may also be useful in your discussions with your study caregiver. The information is not intended to be promotional.
There will be one telephone or video call that should last around one hour. You will be asked questions about being part of the study and what it was like taking or giving the investigational study medication that is being tested in the clinical trial.
Click this link and enter your contact information. A team member will call you and answer any questions you might have. At the end of that call, you can choose whether to take part or not.
No. Sharing your experience is voluntary and you can choose not to participate at any time.
Whether you will be compensated for taking part will depend on where you are located. Please check your information flyer for country-specific details.
No. Study participants and study partners will share their experiences through separate interviews.
F. Hoffman-La Roche Ltd., the GRADUATE study sponsor, is looking to identify potential solutions to any challenges you may have faced during the clinical trial as well as hear about any successes that you may like to share.
All personal information will remain confidential, and data will only be collected and used as necessary to support an individual’s participation in a study. Participants’ names will not be included in any data reported. For more information, including how and why we process personal data, please read our Privacy Policy.